Tag: Gep nets

As of late 2021, the U.S. FDA has approved the first generic version of lanreotide, offering a new alternative to the brand-name drug, Somatuline Depot. The key question, "**Is there a generic for lanreotide?**", now has a definitive "yes" answer, though patients and healthcare providers must consider several factors regarding its use and indications.

Over the past decades, the incidence of neuroendocrine tumors (NETs) has risen, making effective treatment options like lanreotide vital. A lanreotide injection is a long-acting medication that acts as a synthetic hormone, primarily used for managing conditions characterized by excess hormone production, such as acromegaly and certain neuroendocrine tumors.